Venmax Drugs and Pharmaceuticals Limited (BOM:531015)
13.99
-0.99 (-6.61%)
At close: Sep 22, 2026
| Market Cap | 162.05M +17.2% |
| Revenue (ttm) | 92.94M +385.7% |
| Net Income | 3.27M +1,933.5% |
| EPS | 0.24 +691.8% |
| Shares Out | 11.58M |
| PE Ratio | 57.25 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 4,291 |
| Open | 15.00 |
| Previous Close | 14.98 |
| Day's Range | 13.75 - 15.90 |
| 52-Week Range | 12.71 - 31.49 |
| Beta | -1.76 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 12, 2026 |